<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasParagraph>	<http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC161246_doc-5-1-4> .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasParagraph>	<http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC161246_doc-5-1-7> .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"Farmakoterapeutick\u00E1 skupina : L\u00E1tky na atopickou dermatitidu, s v\u00FDjimkou kortikosteroid\u016F \nATC k\u00F3d: D11AFBB \nKyselina salicylov\u00E1 je \u010Dasto pou\u017E\u00EDvan\u00E9 a \u00FA\u010Dinn\u00E9 keratolytikum. Jej\u00ED pou\u017Eit\u00ED vede k deskvamaci a\u00A0\ndestrukci epitelu rozpu\u0161t\u011Bn\u00EDm intercelul\u00E1rn\u00ED matrix stratum korneum. \nKyselina ml\u00E9\u010Dn\u00E1 ovliv\u0148uje proces keratinizace, sni\u017Euje hyperkerat\u00F3zu, m\u00E1 tak\u00E9 leptaj\u00EDc\u00ED \u00FA\u010Dinek, \nkter\u00FD vede k destrukci hyperkeratotick\u00E9 tk\u00E1n\u011B bradavice a vyvol\u00E1vaj\u00EDc\u00EDho viru. \n"@cs .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasSectionTitle>	"5.1. Farmakodynamick\u00E9 vlastnosti "@cs .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"005.001" .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Section> .
<http://linked.opendata.cz/resource/sukl/spc/section/SPC161246_doc-5-1>	<http://salt.semanticauthoring.org/ontologies/sdo#hasParagraph>	<http://linked.opendata.cz/resource/sukl/spc/paragraph/SPC161246_doc-5-1-2> .